Home - Products - MAPK/ERK Signaling - p38 MAPK - sodium lauroyl-α-hydroxyethyl sulfonate

sodium lauroyl-α-hydroxyethyl sulfonate

CAS No. ——

sodium lauroyl-α-hydroxyethyl sulfonate( —— )

Catalog No. M21013 CAS No. ——

Sodium houttuyfonate is anti-pseudomonas agents inhibits virulence-related motility of Pseudomonas.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 58 Get Quote
25MG 104 Get Quote
50MG 145 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    sodium lauroyl-α-hydroxyethyl sulfonate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium houttuyfonate is anti-pseudomonas agents inhibits virulence-related motility of Pseudomonas.
  • Description
    Sodium houttuyfonate is anti-pseudomonas agents inhibits virulence-related motility of Pseudomonas.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    MAPKs| NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    330.41
  • Molecular Formula
    C14H27NaO5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:2 mg/mL(6.1 mM)
  • SMILES
    CCCCCCCCCCCC(=O)CC(O)S(=O)(=O)[O-].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wu DQ et al. Exp Ther Med. 2015 Aug;10(2):753-758.
molnova catalog
related products
  • Asiatic acid

    ActionsAsiatic acid is commonly used in wound healing. Asiatic acid has antioxidant,anti-inflammatory and neuroprotective properties.

  • SB 203580

    A specific p38 MAPK inhibitor with IC50 of 0.6 uM; shows selectivity over JNK, p42 MAPK, p90 S6K, p70 S6K, PKA, etc.

  • PH797804

    PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM in a cell-free assay; 4-fold more selective versus p38β and does not inhibit JNK2. Phase 2.